These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16516100)

  • 21. Thiazolidinediones may be effective in the prevention of stent thrombosis with DES.
    Cao Z; Zhou Y
    Med Hypotheses; 2008; 70(2):329-32. PubMed ID: 17644271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genetics of antiplatelet drug resistance.
    Feher G; Feher A; Pusch G; Lupkovics G; Szapary L; Papp E
    Clin Genet; 2009 Jan; 75(1):1-18. PubMed ID: 19067731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stent thrombosis: a poor man's disease?
    Danenberg HD; Marincheva G; Varshitzki B; Nassar H; Lotan C
    Isr Med Assoc J; 2009 Sep; 11(9):529-32. PubMed ID: 19960845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel.
    Sibbing D; von Beckerath O; Schömig A; Kastrati A; von Beckerath N
    J Thromb Haemost; 2006 Dec; 4(12):2566-8. PubMed ID: 16938125
    [No Abstract]   [Full Text] [Related]  

  • 25. Platelet reactivity as a risk-factor for stent thrombosis: can this be one of the currently available appropriate methods to determine platelet reactivity?
    van Werkum JW; Ten Berg JM
    EuroIntervention; 2008 Aug; 4 Suppl C():C11-6. PubMed ID: 19202685
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug-eluting stent pathology--should we still be cautious?
    Nakazawa G; Finn AV; Virmani R
    Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):1. PubMed ID: 18094669
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiplatelet therapy for patients with stents.
    Med Lett Drugs Ther; 2008 Aug; 50(1292):61-3. PubMed ID: 18688203
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects on blood compatibility in vitro by combining a direct P2Y12 receptor inhibitor and heparin coating of stents.
    Christensen K; Larsson R; Emanuelsson H; Elgue G; Larsson A
    Platelets; 2006 Aug; 17(5):318-27. PubMed ID: 16928604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late blood clots tarnish drug-coated stents. Uncommon complication raises questions about who really needs a drug-coated stent and how long to continue drug therapy after getting one.
    Harv Heart Lett; 2007 Mar; 17(7):4-5. PubMed ID: 17378075
    [No Abstract]   [Full Text] [Related]  

  • 30. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences of platelet adhesion and thrombus activation on amorphous silicon carbide, magnesium alloy, stainless steel, and cobalt chromium stent surfaces.
    Hansi C; Arab A; Rzany A; Ahrens I; Bode C; Hehrlein C
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):488-96. PubMed ID: 19235237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the glass 97% full, or 3% empty? Reinfarction and stent thrombosis after STEMI.
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):635-6. PubMed ID: 19309703
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet activation and progression to complications.
    Kereiakes DJ; Michelson AD
    Rev Cardiovasc Med; 2006; 7(2):75-81. PubMed ID: 16915126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stent thrombosis in the era of drug eluting stents.
    Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-trouble: three cases with simultaneous stent thrombosis in different coronary arteries.
    van Werkum JW; Seesing TH; Suttorp MJ; Bal ET; den Heijer P; Ten Berg JM
    J Interv Cardiol; 2007 Apr; 20(2):132-5. PubMed ID: 17391221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet function testing and implications for clinical practice.
    Collet JP; Montalescot G
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):157-69. PubMed ID: 19721130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
    Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
    Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Very late bare-metal stent thrombosis. A case report and review of the literature.
    Manjappa N; Agarwal A; Cavusoglu E
    J Invasive Cardiol; 2006 Jul; 18(7):E203-6. PubMed ID: 16816449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel thromboresistant materials.
    Jordan SW; Chaikof EL
    J Vasc Surg; 2007 Jun; 45 Suppl A():A104-15. PubMed ID: 17544031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.